Vanda Pharmaceuticals (VNDA) Tops Q4 EPS by 8c
Tweet
Share
E-mail
Get Alerts VNDA Hot Sheet
Price: $5.26 +0.77%
Financial Fact:
Total operating expenses: 39.14M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Total operating expenses: 39.14M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q4 EPS of ($0.01), $0.08 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $38.24 million versus the consensus estimate of $38.39 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- The LGL Group (LGL) Misses Q2 EPS by 8c
- Tesla to launch Cybercab in Austin this month - report
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
